Rémi B.
- Country
- France
- Department
- Radiotherapy Oncology
Research Overview
Data & Insights
Has run more than one trial at 11 of 58 partner sites.
Specializations
Advanced Lung Cancer Treatment
The investigator specializes in treating advanced non-small cell lung cancer (NSCLC), with particular focus on integrating immunotherapy approaches and PD-1 antagonist treatments. Their expertise extends to combining various therapeutic modalities including chemotherapy and radiation therapy.
- Stage IIIB/IIIC/IV NSCLC management
- Immunotherapy integration strategies
- Combined therapeutic approaches
Their work encompasses innovative treatment protocols for patients eligible for first-line immunotherapy treatments.
Small Cell Lung Cancer Innovation
The investigator focuses on developing treatments for limited disease small cell lung cancer (LD-SCLC), particularly in treating vulnerable patient populations. Their expertise includes thoracic chemoradiotherapy and immunotherapy maintenance strategies.
- Frail patient treatment protocols
- Durvalumab maintenance therapy
- Elderly patient care management
Their research addresses specific needs of patients with performance status limitations and those over 70 years of age.
Therapeutic Innovation
The investigator's work centers on evaluating novel therapeutic combinations in lung cancer treatment, including concurrent radiation with immunotherapy and maintenance treatment strategies. Their research emphasizes measuring treatment outcomes through survival rates and progression-free survival.
- Combined modality treatments
- Treatment response assessment
- Patient-specific therapy adaptation
Their approach incorporates comprehensive evaluation of treatment efficacy using established clinical criteria.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.